Researchers have developed the Drug Resistance Index (DRI) which combines antibiotic consumption measurements with resistance data to compare aggregate resistance across time and between countries.
Misdiagnosis of infection strains in hospitals is leading to a public health crisis, as doctors treat these infections unnecessarily and ineffectively with antibiotics. To tackle this, new precision medicine solutions are being tested.
Researchers analyzed antibiotic resistance genes in urban wastewater collected at wastewater treatment plants in seven European countries and found that the amount of resistance genes was higher in the wastewater from countries with higher antibiotic use.
These data suggest that increased use of antibiotics in specific geographical areas is associated with an increased personal risk of acquiring antibiotic-resistant bacteria, independent of personal history of antibiotic consumption and other known risk factors for antimicrobial resistance.
Clinical microbiology has long relied on growing bacteria in culture to determine antimicrobial susceptibility profiles, but the use of whole-genome sequencing for antibiotic susceptibility testing is now a powerful alternative.
Data released today by the European Centre for Disease Prevention and Control (ECDC) and European Food Safety Authority (EFSA) reveal that antimicrobials used to treat diseases that can be transmitted between animals and humans, such as campylobacteriosis and salmonellosis, are becoming less effective.
This free afternoon event is a public launch of a special issue of the Annals of the New York Academy of Sciences. The authors will present the conclusions of an expert committee convened to discuss antibiotic use in food animal production and its relation to human health.
Researchers are worried about the fast development and spread of "superbugs," which are bacteria that do not respond to antibiotics. For the first time, scientists have found potent superbugs in the remote High Arctic of Norway, which they fear does not bode well for the future of antibiotic treatments.
The London School of Hygiene & Tropical Medicine Antimicrobial Resistance Center, together with the MARCH and Malaria Centres will jointly host the Mass Drug Administration and Antimicrobial Resistance Symposium on 20 February 2019 in London, UK and by live stream. This symposium will bring together academics from a range of relevant disciplines to discuss the state of evidence, and draw out a future integrated research agenda that addresses potential hurdles with this approach, including concerns about antimicrobial resistance.
The plans outline the UK's contribution to containing and controlling antimicrobial resistance in health, animals, the environment, and the food chain.